• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尼日利亚翁多州采用伊维菌素进行群体定向治疗(CDTI)治疗盘尾丝虫病和罗阿丝虫病的不良反应。

Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.

作者信息

Otubanjo O A, Adeoye G O, Ibidapo C A, Akinsanya B, Okeke P, Atalabi T, Adejai E T, Braide E

机构信息

Department of Zoology, University of Lagos, Akoka, Yaba, Lagos, Nigeria.

出版信息

Rev Biol Trop. 2008 Dec;56(4):1635-43. doi: 10.15517/rbt.v56i4.5750.

DOI:10.15517/rbt.v56i4.5750
PMID:19419072
Abstract

Onchocerciasis is an endemic disease in Ondo state, Nigeria. Community directed distribution of ivermectin is currently on-going in some local government areas of the state. Randomly selected persons (2331 males and 2469 females) were interviewed using a modified rapid assessment procedure for Loa loa (RAPLOA) to assess community directed treatment with ivermectin. The retrospective study evaluated the coverage, impacts and adverse reactions to the drug treatment. A questionnaire was administered by house-to-house visit in six local government areas, implementing community directed treatment with ivermectin (CDTI) in this bioclimatic zone. A total of 2,398 respondents were reported to have participated in the treatment. The overall ivermectin coverage of 49.96% was recorded (range 0-52% in different communities). Adverse reactions from ivermectin administration were experienced in 38% of individuals. Diverse adverse reactions experienced included predominantly itching (18.50%); oedema, especially of the face and the limbs (8.2%); rashes (3.4%) and body weakness (2.4%). Expulsion of intestinal worms occurred in 0.96% of the respondents. The occurrence of adverse reactions in relation to age categories was statistically significant. Neither fatal nor severe adverse reactions were reported by respondents. Significantly, despite experienced adverse reactions, continued participation, acceptability and compliance to ivermectin treatment was expressed by the various communities. This attitude is in consonance with the African Programme for Onchocerciasis Control (APOC) objectives. Rev. Biol.

摘要

盘尾丝虫病是尼日利亚翁多州的一种地方病。目前该州一些地方政府辖区正在进行伊维菌素的社区定向分发。采用改良的罗阿丝虫快速评估程序(RAPLOA)对随机挑选的人员(2331名男性和2469名女性)进行访谈,以评估伊维菌素的社区定向治疗情况。这项回顾性研究评估了药物治疗的覆盖范围、影响及不良反应。通过逐户走访,在六个地方政府辖区实施了伊维菌素社区定向治疗(CDTI),该地区属于生物气候区。据报告,共有2398名受访者参与了治疗。伊维菌素的总体覆盖率为49.96%(不同社区的覆盖率范围为0 - 52%)。38%的个体出现了伊维菌素给药后的不良反应。出现的各种不良反应主要包括瘙痒(18.50%);水肿,尤其是面部和四肢水肿(8.2%);皮疹(3.4%)和身体虚弱(2.4%)。0.96%的受访者出现了肠道蠕虫排出的情况。不良反应在不同年龄组中的发生情况具有统计学意义。受访者均未报告致命或严重的不良反应。值得注意的是,尽管出现了不良反应,但各个社区仍表示会继续参与、接受并遵守伊维菌素治疗。这种态度与非洲盘尾丝虫病控制计划(APOC)的目标一致。《生物学评论》

相似文献

1
Adverse reactions from community directed treatment with ivermectin (CDTI) for onchocerciasis and loiasis in Ondo State, Nigeria.尼日利亚翁多州采用伊维菌素进行群体定向治疗(CDTI)治疗盘尾丝虫病和罗阿丝虫病的不良反应。
Rev Biol Trop. 2008 Dec;56(4):1635-43. doi: 10.15517/rbt.v56i4.5750.
2
Market survey of loiasis: prevalence and adverse reactions to ivermectin using a rapid procedure for loiasis.罗阿丝虫病的市场调查:采用罗阿丝虫病快速检测方法对伊维菌素的患病率及不良反应进行调查
West Indian Med J. 2008 Mar;57(2):152-6.
3
Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA).通过盘尾丝虫病快速评估程序(RAPLOA)评估的尼日利亚翁多州盘尾丝虫病患病率。
Ann Trop Med Parasitol. 2008 Apr;102(3):215-27. doi: 10.1179/136485908X267867.
4
Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.在喀麦隆,反复进行年度社区伊维菌素给药治疗对盘尾丝虫病寄生虫学指标的影响:对在非洲与盘尾丝虫病和淋巴丝虫病共同流行地区消除盘尾丝虫病和淋巴丝虫病的影响。
PLoS Negl Trop Dis. 2018 Sep 18;12(9):e0006750. doi: 10.1371/journal.pntd.0006750. eCollection 2018 Sep.
5
Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.尼日利亚西南部雨林社区中罗阿丝虫病和盘尾丝虫病的共同流行情况。
PLoS Negl Trop Dis. 2015 Mar 26;9(3):e0003633. doi: 10.1371/journal.pntd.0003633. eCollection 2015 Mar.
6
A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.罗阿丝虫病流行地区盘尾丝虫病的检测而非治疗策略。
N Engl J Med. 2017 Nov 23;377(21):2044-2052. doi: 10.1056/NEJMoa1705026. Epub 2017 Nov 8.
7
Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.在罗阿丝虫感染流行地区用伊维菌素大规模治疗盘尾丝虫病后的严重反应。
Lancet. 1997 Jul 5;350(9070):18-22. doi: 10.1016/S0140-6736(96)11094-1.
8
Loiasis is endemic in the Ndikinimeki Health District (Centre Region, Cameroon) but does not represent a hindrance to onchocerciasis elimination.洛矶山热流行于 Ndikinimeki 卫生区(喀麦隆中心大区),但不会对消灭盘尾丝虫病造成阻碍。
Acta Trop. 2022 Jan;225:106218. doi: 10.1016/j.actatropica.2021.106218. Epub 2021 Oct 30.
9
Assessment of loiasis and outcomes of ivermectin masstreatment in Ijebu-North, Nigeria.尼日利亚伊杰布北区罗阿丝虫病评估及伊维菌素群体治疗效果
Korean J Parasitol. 2011 Jun;49(2):153-9. doi: 10.3347/kjp.2011.49.2.153. Epub 2011 Jun 14.
10
Structure of the microfilarial reservoir of Loa loa in the human host and its implications for monitoring the progr,ammes of Community-Directed Treatment with Ivermectin carried out in Africa.人体宿主中罗阿丝虫微丝蚴储存库的结构及其对监测非洲开展的伊维菌素社区导向治疗项目的意义。
Parasitology. 2004 Nov;129(Pt 5):613-26. doi: 10.1017/s0031182004005694.

引用本文的文献

1
Variation of adverse drug events in different settings in Africa: a systematic review.非洲不同环境下药物不良反应的变化:系统评价。
Eur J Med Res. 2024 Jun 16;29(1):333. doi: 10.1186/s40001-024-01934-0.
2
Infectivity of Simulium damnosum s.l. and therapeutic coverage of ivermectin distribution 10 years post treatment around Owena Dam, Ondo state, Nigeria.在尼日利亚翁多州 Owena 大坝周围,经过伊维菌素治疗 10 年后,传播媒介蚋属(Simulium damnosum s.l.)的感染性和伊维菌素分布的治疗覆盖率。
Braz J Infect Dis. 2019 Nov-Dec;23(6):410-418. doi: 10.1016/j.bjid.2019.10.003. Epub 2019 Nov 4.
3
Analysis of severe adverse effects following community-based ivermectin treatment in the Democratic Republic of Congo.
分析刚果民主共和国社区伊维菌素治疗后的严重不良影响。
BMC Pharmacol Toxicol. 2019 Aug 16;20(1):49. doi: 10.1186/s40360-019-0327-5.
4
Evaluation of Treatment Coverage and Enhanced Mass Drug Administration for Onchocerciasis and Lymphatic Filariasis in Five Local Government Areas Treating Twice Per Year in Edo State, Nigeria.尼日利亚埃多州五个地方政府区两年一次治疗盘尾丝虫病和淋巴丝虫病的治疗覆盖率评估和强化大规模药物治疗。
Am J Trop Med Hyg. 2018 Aug;99(2):396-403. doi: 10.4269/ajtmh.17-1004. Epub 2018 Jun 21.
5
Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.被忽视热带病控制项目中驱虫治疗的依从性:一项系统综述
Parasit Vectors. 2016 Jan 27;9:29. doi: 10.1186/s13071-016-1311-1.
6
Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.尼日利亚西南部雨林社区中罗阿丝虫病和盘尾丝虫病的共同流行情况。
PLoS Negl Trop Dis. 2015 Mar 26;9(3):e0003633. doi: 10.1371/journal.pntd.0003633. eCollection 2015 Mar.